Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery
View Patent ↗The present invention provides a tumor-homing peptide that can target cancer and or tumor tissues. The peptide is uptaken by certain specific cancer cell types. The invention describes methods to achieve targeted delivery of anticancer drugs conjugated to this peptide for anticancer therapy. The invention also describes methods for using the peptide for the diagnosis and imaging of cancer and tumor tissues.
1. An isolated peptide that targets a tumor cell, wherein said peptide comprises the amino acid sequence of SEQ ID NO:1.
2. The peptide of claim 1 , consisting of SEQ ID NO:1.
3. A composition comprising:
a) an anti-cancer drug; and
b) a peptide that targets a tumor cell, wherein said peptide comprises the amino acid sequence of SEQ ID NO:1.
4. The composition of claim 3 , wherein said peptide consists of SEQ ID NO:1.
5. The composition of claim 3 , wherein said drug is a chemotherapeutic agent.
6. The composition of claim 3 , wherein said drug is a cytotoxic agent.
7. The composition of claim 3 , wherein said drug is an apoptotic agent.
8. The composition of claim 3 , wherein said drug is a DNA-damaging agent.
9. The composition of claim 3 , wherein said drug is plant alkaloid.
10. The composition of claim 3 , wherein said drug is cisplatin (CDDP), carboplatin, procarbazine, mechlorethamine, cyclophosphamide, ifosfamide, melphalan, chiorambucil, bisulfan, nitrosurea, dactinomycin, daunorubicin, doxorubicin, bleomycin, plicomycin, mitomycin, etoposide (VP16), tamoxifen, transplatinum, 5-fluorouracil, vincristin, vinblastin or methotrexate.
11. The peptide of claim 1 , wherein said peptide is internalized by said tumor cell.
12. The composition of claim 3 , wherein said peptide is internalized by said tumor cell.
13. The composition of claim 9 , wherein said plant alkaloid is paclitaxel.